TheraRadar
← Back
Data updated: Jun 28, 2026

CR DOUBLE CRANE

Generics
Pharmaceuticals

CR DOUBLE CRANE is a generic drug manufacturer with 2 FDA-approved products.

2002
Since
2
Drugs
-
Trials
0
New Drugs (2yr)

CR DOUBLE CRANE's Key Drugs

CR DOUBLE CRANE's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

CR DOUBLE CRANE's Recent FDA Approvals

New NDA/BLA approvals for CR DOUBLE CRANE over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

CR DOUBLE CRANE's Therapeutic Areas

Disease areas where CR DOUBLE CRANE has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

CR DOUBLE CRANE Pipeline Snapshot

Active clinical trials for CR DOUBLE CRANE across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling